Abiopharma

🔍 Carter Donald Chad (Executive)

Company: Business First Bancshares, Inc. (BFST)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Sold 317 shares of COMMON STOCK at $27.04 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 14,517.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 9,319 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 9,319.00 | Footnotes: F2, F2, F2

Footnotes:

• F1: Includes units of the employer stock fund through the issuer's 401(k) plan equivalent to 6,799 shares of common stock of the issuer.
• F2: Includes: (a) 2,584 time-based restricted stock units granted on December 12, 2024, which will vest in two substantially equal installments on the second and third anniversary of the issuance date; (b) 2,715 time-based restricted stock units granted to the reporting person on March 1, 2025, which will vest in two substantially equal installments on the second and third anniversary of the issuance date; and (c) 4,020 time-based restricted stock units granted to the reporting person on March 2, 2026, which will vest in three substantially equal installments on the first, second, and third anniversary of the issue date.